Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Live Tissue Connect CE marks forceps for VAD.400 generator

This article was originally published in Clinica

Executive Summary

Live Tissue Connect has CE marked its bipolar forceps for sale in Europe, which are used exclusively with its VAD.400 radiofrequency generator. The firm, a subsidiary of CSMG Technologies (Corpus Christi, Texas), CE marked the generator in December 2007 (see Clinica No 1285, p 18). The entire VAD system, which includes the VAD.400 generator and the forceps, which consist of two configurations of disposable instruments, received US FDA 510(k) clearance last month (see Clinica No 1319, p 18). The system is used in general surgery and gynaecology for sealing arteries, veins and ducts, and the forceps are an alternative to clamping with clips and staples, and suturing.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel